跳转至内容
Merck
CN

AB1056

抗腺病毒抗体

Chemicon®, from goat

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
polyclonal
Species reactivity:
human
Application:
ELISA, IF, IHC, WB
Citations:
41
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

goat

antibody form

purified antibody

antibody product type

primary antibodies

clone

polyclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable, immunofluorescence: suitable, immunohistochemistry: suitable, western blot: suitable

shipped in

wet ice

Quality Level

Immunogen

来自5型腺病毒的六邻体。

Application

研究类别
传染病
该抗腺病毒抗体经验证可用于ELISA、IF、WB、IH检测腺病毒。
ELISA:>1:5,000

间接荧光显微镜检查。

免疫印迹:仅1 mM DTT和2%SDS中的未煮沸样品

免疫组化

最佳工作稀释度必须由最终用户进行确定
研究子类别
传染病 - 病毒

Biochem/physiol Actions

腺病毒,六邻体组装。与Para 1-3、流行性感冒A & B或RSV无交叉反应。与HEp-2细胞无反应。

Physical form

IgG部分(纯度>95%)。 在PBS(0.01 M,pH 7.2)中,含0.1%叠氮化钠
形式:纯化

Preparation Note

自收到之日起,在-20°下以未稀释的等分试样可保存12个月。应避免反复冻/融循环。

Other Notes

浓度:请参考批次特异性浓缩物的检验报告。

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Nuclear import of adenovirus DNA in vitro involves the nuclear protein import pathway and hsc70.
A C Saphire, T Guan, E C Schirmer, G R Nemerow, L Gerace
The Journal of Biological Chemistry null
Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.
T Nishimoto,K Yoshida,Y Miura,A Kobayashi,H Hara,S Ohnami,K Kurisu,T Yoshida,K Aoki
Gene Therapy null
J-W Choi et al.
Gene therapy, 20(9), 880-892 (2013-03-22)
Adenoviruses (Ad) have been investigated for their efficacy in reducing primary tumors after local intratumoral administration. Despite high Ad concentrations and repetitive administration, the therapeutic efficacy of Ad has been limited because of rapid dissemination of the Ad into the
Marc Garcia-Moure et al.
Scientific reports, 9(1), 14368-14368 (2019-10-09)
Last advances in the treatment of pediatric tumors has led to an increase of survival rates of children affected by primitive neuroectodermal tumors, however, still a significant amount of the patients do not overcome the disease. In addition, the survivors
Lynette M Phillips et al.
Neuro-oncology, 23(11), 1911-1921 (2021-06-02)
Oncolytic adenoviruses are promising new treatments against solid tumors, particularly for glioblastoma (GBM), and preclinical models are required to evaluate the mechanisms of efficacy. However, due to the species selectivity of adenovirus, there is currently no single animal model that

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持